ARDM - Aradigm Corporation
| Previous Close | 1.53 |
| Open | 1.53 |
| Bid | 1.50 x 4500 |
| Ask | 1.53 x 900 |
| Day's Range | 1.51 - 1.54 |
| 52 Week Range | 0.78 - 7.35 |
| Volume | 15,011 |
| Avg. Volume | 177,174 |
| Market Cap | 22.192M |
| Beta | 1.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.72 |
| Earnings Date | Mar 26, 2018 - Mar 30, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 1996-03-01 |
| 1y Target Est | 10.00 |
- GlobeNewswire•8 days ago
New Research Coverage Highlights Aradigm, Ultra Petroleum, TRI Pointe Group, Finisar, Tesla, and The Progressive — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, April 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
- ACCESSWIRE•15 days ago
Wired News – EMA Completed Validation of MAA for Aradigm’s Linhaliq in Non-Cystic Fibrosis Bronchiectasis
Stock Monitor: Bio-Path Holdings Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 09, 2018 / Active-Investors.com has just released a free research report on Aradigm Corp. (NASDAQ: ARDM ). If you ...
- Business Wire•19 days ago
Aradigm Announces the EMA Has Completed Its Validation of the MAA Submission
Aradigm Corporation today announced the completed formal validation by the European Medicines Agency of the Marketing Authorisation Application for Linhaliq for the treatment of non-cystic fibrosis bronchiectasis patients with chronic lung infections with Pseudomonas aeruginosa (P.
- Associated Press•last month
Aradigm reports 4Q loss
On a per-share basis, the Hayward, California-based company said it had a loss of 28 cents. The specialty pharmaceutical company posted revenue of $2.4 million in the period. For the year, the company ...
- Business Wire•last month
Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results
Aradigm Corporation today announced financial results for the fourth quarter and full year ended December 31, 2017.
- ACCESSWIRE•last month
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / March 12, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aradigm Corporation ("Aradigm" ...
- ACCESSWIRE•last month
FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018
NEW YORK, NY / ACCESSWIRE / March 12, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aradigm Corporation (''Aradigm'' or the ''Company'') ...
- Zacks•last month
Aradigm Files MAA for Bronchiectasis Candidate in the EU
Aradigm (ARDM) submits regulatory applications for its bronchiectasis candidate, Linhaliq, in the EU. A response from the EMA is awaited within 21 days to notify if the filing is complete.
- ACCESSWIRE•last month
The Klein Law Firm Reminds Shareholders of Aradigm Corporation of a Class Action and a Lead Plaintiff Deadline of March 12, 2018 (ARDM)
NEW YORK, NY / ACCESSWIRE / March 12, 2018 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Aradigm Corporation (NASDAQ: ARDM) who purchased shares ...
- Business Wire•last month
Glancy Prongay & Murray LLP Reminds Investors of the March 12, 2018 Deadline in the Class Action Lawsuit Against Aradigm Corporation
Glancy Prongay & Murray LLP reminds investors of the March 12, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Aradigm Corporation securities between July 27, 2017 and January 8, 2018, inclusive .
- ACCESSWIRE•last month
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / March 10, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aradigm Corporation ("Aradigm" ...
- Business Wire•2 months ago
ARADIGM INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Aradigm Corporation to Contact the Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Aradigm Corporation of the March 12, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
- Business Wire•2 months ago
March 12th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aradigm Corporation (ARDM)
Law Offices of Howard G. Smith reminds investors of the March 12, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Aradigm Corporation securities between July 27, 2017 and January 8, 2018, inclusive .
- ACCESSWIRE•2 months ago
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDM
NEW YORK, NY / ACCESSWIRE / March 9, 2018 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Aradigm Corporation ...
- ACCESSWIRE•2 months ago
DEADLINE REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation And Reminds Investors With Losses To Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / March 9, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aradigm Corporation ("Aradigm" ...
- Business Wire•2 months ago
Aradigm Submits Marketing Authorisation Application (MAA) to EMA for EU Marketing Approval of Linhaliq in Non-Cystic Fibrosis Bronchiectasis
Aradigm Corporation today announced it has submitted its Marketing Authorisation Application to European Medicines Agency for Linhaliq™ for the treatment of non-cystic fibrosis bronchiectasis patients with chronic lung infection with Pseudomonas aeruginosa (P.
- Business Wire•2 months ago
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Aradigm Corporation Investors (ARDM)
Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors that purchased Aradigm Corporation securities between July 27, 2017 and January 8, 2018, inclusive .
- ACCESSWIRE•2 months ago
ARDM EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018
NEW YORK, NY / ACCESSWIRE / March 8, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors ...
- ACCESSWIRE•2 months ago
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
LOS ANGELES, CA / ACCESSWIRE / March 8, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aradigm Corporation ("Aradigm" ...
- ACCESSWIRE•2 months ago
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Aradigm Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 12, 2018 - ARDM
NEW YORK, NY / ACCESSWIRE / March 7, 2018 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Aradigm Corporation ...
- ACCESSWIRE•2 months ago
5-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
LOS ANGELES, CA / ACCESSWIRE / March 7, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aradigm Corporation ("Aradigm" ...
- GlobeNewswire•2 months ago
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Aradigm Corporation (ARDM) & Lead Plaintiff Deadline: March 12, 2018
NEW YORK, March 07, 2018-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Aradigm Corporation and certain of its officers, ...
- Business Wire•2 months ago
ARDM INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Aradigm Corporation Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Aradigm Corporation securities between July 27, 2017 and January 8, 2018, inclusive .
- ACCESSWIRE•2 months ago
ARDM EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Aradigm Corporation and a Lead Plaintiff Deadline of March 12, 2018
NEW YORK, NY / ACCESSWIRE / March 6, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors ...
- ACCESSWIRE•2 months ago
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Aradigm Corporation
LOS ANGELES, CA / ACCESSWIRE / March 5, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Aradigm Corporation ("Aradigm" ...
